Fortress' brain injury drug gets FDA RMAT designation

05:20 EST 10 Nov 2017 | SmartBrief

A regenerative medicine advanced therapy designation was granted by the FDA to Fortress Biotech's CEVA101, which is being ass -More

Original Article: Fortress' brain injury drug gets FDA RMAT designation


More From BioPortfolio on "Fortress' brain injury drug gets FDA RMAT designation"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...